| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.05 | 0.00 (0.00%) | 0.017 - 0.30 | 0.0 |
Market data as of 12:00AM 05/22/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 0.05 |
| Day's Range | -- - -- |
| Market Cap | 1.5M |
| Avg Volume (10 Day) | 12.6K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.12 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Fail |
| Have investors caught on? | Neutral |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Fail |
No news headlines available for ALSE
| ALSE | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | -- |
| Company | Last | Change |
|---|---|---|
| Alcobra Ltd | 7.42 | -1.72% |
| OXiGENE Inc | 3.33 | +1.52% |
| Insys Therapeutics Inc | 10.35 | +1.67% |
| ARCA Biopharma Inc | 2.43 | -5.07% |
| Oxygen Biotherapeutics Inc | 4.21 | -5.41% |
Data is delayed by at least 15 min.